跳至主要内容
临床试验/NCT07595120
NCT07595120尚未招募不适用

Electromagnetic Navigation-Guided Versus CT-Guided Localization of Pulmonary Nodules: A Multicenter, Prospective, Randomized Controlled Trial

Shanghai Pulmonary Hospital, Shanghai, China1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2026年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
400
试验地点
1

研究概览

简要总结

This study aims to design and conduct a multicenter, prospective, randomized controlled post-market clinical trial to validate the clinical efficacy of high-precision electromagnetic navigation technology.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-80 years, regardless of gender;
  • Solitary single nodule, scheduled for lung nodule puncture and localization;
  • Chest CT (lung window mode) showing a maximum nodule diameter ≤ 2 cm;
  • Eastern Cooperative Oncology Group (ECOG) performance status score 0-2;
  • Voluntary participation, with signed informed consent.

排除标准

  • Not suitable for video-assisted thoracoscopic surgery;
  • The distance between the center of the lesion and the dome of the diaphragm is < 3 cm;
  • History of thoracic adhesion due to previous thoracotomy or pleural infection;
  • Patients judged by the investigator to be unsuitable for preoperative transthoracic or transbronchial localization;
  • Inability to complete follow-up or poor compliance.

研究组 & 干预措施

Electromagnetic Navigation Localization Group

Experimental

干预措施: Electromagnetic Navigation-Guided Percutaneous Localization of Pulmonary Nodules (Procedure)

CT-Guided Localization Group

Active Comparator

干预措施: CT-Guided Percutaneous Localization of Pulmonary Nodules (Procedure)

研究者

发起方
Shanghai Pulmonary Hospital, Shanghai, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Haifeng Wang

Prof.

Shanghai Pulmonary Hospital, Shanghai, China

研究点 (1)

Loading locations...

相似试验